Corneal Ulcers - Pipeline Review, H2 2015

Publisher Name :
Date: 09-Dec-2015
No. of pages: 39
Inquire Before Buying

Global Markets Direct's, ‘Corneal Ulcers - Pipeline Review, H2 2015', provides an overview of the Corneal Ulcers's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Corneal Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Corneal Ulcers and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Corneal Ulcers

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Corneal Ulcers and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Corneal Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Corneal Ulcers pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Corneal Ulcers

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Corneal Ulcers pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Corneal Ulcers - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Corneal Ulcers Overview 6
Therapeutics Development 7
Pipeline Products for Corneal Ulcers - Overview 7
Pipeline Products for Corneal Ulcers - Comparative Analysis 8
Corneal Ulcers - Therapeutics under Development by Companies 9
Corneal Ulcers - Therapeutics under Investigation by Universities/Institutes 10
Corneal Ulcers - Pipeline Products Glance 11
Early Stage Products 11
Corneal Ulcers - Products under Development by Companies 12
Corneal Ulcers - Products under Investigation by Universities/Institutes 13
Corneal Ulcers - Companies Involved in Therapeutics Development 14
Amakem NV 14
Digna Biotech, S.L. 15
Lee's Pharmaceutical Holdings Limited 16
Corneal Ulcers - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
AMA-0526 - Drug Profile 26
Mechanism of Action 26
R&D Progress 26
disitertide - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
LQ-7 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
P-17 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecules for Parasitic Corneal Ulcers - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
ZK-003 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Corneal Ulcers - Recent Pipeline Updates 35
Corneal Ulcers - Dormant Projects 36
Corneal Ulcers - Discontinued Products 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39

List of Tables

Number of Products under Development for Corneal Ulcers, H2 2015 7
Number of Products under Development for Corneal Ulcers - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Early Stage Products, H2 2015 11
Products under Development by Companies, H2 2015 12
Products under Investigation by Universities/Institutes, H2 2015 13
Corneal Ulcers - Pipeline by Amakem NV, H2 2015 14
Corneal Ulcers - Pipeline by Digna Biotech, S.L., H2 2015 15
Corneal Ulcers - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015 16
Assessment by Monotherapy Products, H2 2015 17
Number of Products by Stage and Target, H2 2015 19
Number of Products by Stage and Mechanism of Action, H2 2015 21
Number of Products by Stage and Route of Administration, H2 2015 23
Number of Products by Stage and Molecule Type, H2 2015 25
Corneal Ulcers Therapeutics - Recent Pipeline Updates, H2 2015 35
Corneal Ulcers - Dormant Projects, H2 2015 36
Corneal Ulcers - Discontinued Products, H2 2015 37

List of Figures

Number of Products under Development for Corneal Ulcers, H2 2015 7
Number of Products under Development for Corneal Ulcers - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Comparative Analysis by Early Stage Products, H2 2015 11
Assessment by Monotherapy Products, H2 2015 17
Number of Products by Targets, H2 2015 18
Number of Products by Stage and Targets, H2 2015 18
Number of Products by Mechanism of Actions, H2 2015 20
Number of Products by Stage and Mechanism of Actions, H2 2015 20
Number of Products by Routes of Administration, H2 2015 22
Number of Products by Stage and Routes of Administration, H2 2015 22
Number of Products by Molecule Types, H2 2015 24
Number of Products by Stage and Molecule Types, H2 2015 24
  • Global Sustained Release Ocular Drug Delivery Systems Market Professional Survey Report 2017
    Published: 12-Dec-2017        Price: US 3500 Onwards        Pages: 118
    This report studies Sustained Release Ocular Drug Delivery Systems in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - pSivida - Allergan - Icon Bioscience ......
  • China Artificial Tears Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 08-Dec-2017        Price: US 4480 Onwards        Pages: 124
    This report studies the Artificial Tears market, Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. Scope of the Report: This report focuses on the Artificial Tears in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Seg......
  • Global Eye Drops & Lubricants Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Eye Drops & Lubricants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Eye Drops & Lubricants for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • United States Ophthalmic Therapeutic Drugs Market Report 2017
    Published: 06-Dec-2017        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gr......
  • China Conjunctivitis Market Research Report 2017
    Published: 06-Dec-2017        Price: US 3400 Onwards        Pages: 112
    The global Conjunctivitis market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Conjunctivitis development status and future trend in China, focuses on top players in China, also splits Conjunctivitis b......
  • United States Latanoprost Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 05-Dec-2017        Price: US 4480 Onwards        Pages: 119
    "Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressur......
  • Global Ophthalmic Therapeutic Drugs Sales Market Report 2017
    Published: 01-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Ophthalmic Therapeutic Drugs for these regions, from 2012 to 2022 (forecast) , covering - United States - China ......
  • Macular Edema - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 42
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Pipeline Review, H2 2017, provides an overview of the Macular Edema (Ophthalmology) pipeline landscape. Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently ......
  • Retinal Vein Occlusion - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 90
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinal Vein Occlusion - Pipeline Review, H2 2017, provides an overview of the Retinal Vein Occlusion (Ophthalmology) pipeline landscape. Retinal vein occlusion is a blockage in one of the veins returning blood flow from the retina. The retina is where images are converted to nerve signals. The primary symptom of retinal vein occlusion is a sudden painless change in vis......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs